Search

Search results

427 results found

Renal Denervation in Hypertension and Chronic Heart Failure.

Publication: Journal Article

Lauder, Lucas, Naomi D L Fisher, Michael Böhm, Otmar Pfister, Eric A Secemsky, Pam R Taub, and Felix Mahfoud. 2025. “Renal Denervation in Hypertension and Chronic Heart Failure.”. JACC. Cardiovascular Interventions 18 (15): 1833-47.

APPLICATION CLOSED - Full-time Post-Doctoral position available: AI-PAD Project with EHESP School of Public Health (France)

News: May 15, 2025

Project Title: AI-PAD (Artificial intelligence for fair prediction of adverse outcomes following revascularization for lower limb peripheral arterial disease using French health information systems). Location: This full-time position is based in Rennes, France. Application Deadline: August 15, 2025...

Renal Denervation Registry

Page

Renal denervation (RDN), a novel procedure where renal artery nerves are strategically ablated to lower blood pressure, is a minimally invasive method of treating patients whose hypertension is not well-controlled with pharmacology. Dr. Secemsky co-led a clinical study on RDN that helped inform the...

Drug-coated vs non-drug-coated devices for femoropopliteal artery interventions: long-term outcomes of the SAFE-PAD study.

Publication: Journal Article

Kim, Joseph M, Robert W Yeh, Yang Song, and Eric A Secemsky. 2025. “Drug-Coated Vs Non-Drug-Coated Devices for Femoropopliteal Artery Interventions: Long-Term Outcomes of the SAFE-PAD Study.”. European Heart Journal.

An International, Expert-based, Multispecialty Delphi Consensus Document on Stroke Risk Stratification and the Optimal Management of Patients with Asymptomatic and Symptomatic Carotid Stenosis.

Publication: Journal Article

Paraskevas, Kosmas I, Ali F AbuRahma, Wesley S Moore, Peter Gloviczki, Bruce A Perler, Daniel G Clair, Christopher J White, et al. 2025. “An International, Expert-Based, Multispecialty Delphi Consensus Document on Stroke Risk Stratification and the Optimal Management of Patients With Asymptomatic and Symptomatic Carotid Stenosis.”. Journal of Vascular Surgery.

Impact of COVID-19 Pandemic on Treatment and Outcome of Patients With Femoropopliteal Peripheral Arterial Disease.

Publication: Journal Article

Naderian, Mohammadreza, Jun Li, Yulanka Castro-Dominguez, Tarek Hammad, Clint Oommen, Herbert D Aronow, Eric A Secemsky, and Mehdi H Shishehbor. 2025. “Impact of COVID-19 Pandemic on Treatment and Outcome of Patients With Femoropopliteal Peripheral Arterial Disease.”. Journal of the Society for Cardiovascular Angiography & Interventions 4 (9): 103816.

Global Trends and Forecast of Cardiovascular Diseases, Cancer, and Shared Risk Factors: Insights From the GBD 2021.

Publication: Journal Article

Koo, Chieh Y, Bryan Chong, Jayanth Jayabaskaran, Srinithy Nagarajan, Silingga M Jauhari, Yiming Chen, Li L Tan, et al. 2025. “Global Trends and Forecast of Cardiovascular Diseases, Cancer, and Shared Risk Factors: Insights From the GBD 2021.”. Journal of the American Heart Association, e043629.

Search

Search results

Renal Denervation in Hypertension and Chronic Heart Failure.

APPLICATION CLOSED - Full-time Post-Doctoral position available: AI-PAD Project with EHESP School of Public Health (France)

Renal Denervation Registry

Drug-coated vs non-drug-coated devices for femoropopliteal artery interventions: long-term outcomes of the SAFE-PAD study.

An International, Expert-based, Multispecialty Delphi Consensus Document on Stroke Risk Stratification and the Optimal Management of Patients with Asymptomatic and Symptomatic Carotid Stenosis.

Impact of COVID-19 Pandemic on Treatment and Outcome of Patients With Femoropopliteal Peripheral Arterial Disease.

Global Trends and Forecast of Cardiovascular Diseases, Cancer, and Shared Risk Factors: Insights From the GBD 2021.

Bharath Rathakrishnan, MD

Michael Gurin, MD, MS

Chien-Yu Huang, PhD